Chen, Rongjie
Zhang, Shuo
Liu, Shanggong
Liao, Feng
Sun, Ying
Chen, Yi
Liang, Jiaqi
Liu, Jiangyue
Chen, Gong
Lei, Wenliang https://orcid.org/0000-0002-7954-7214
Funding for this research was provided by:
National Natural Science Foundation of China (32571169)
Guangdong Innovative and Entrepreneurial Research Team Program (2021ZT09Y552)
Guangdong Innovative and Entrepreneurial Research Team Program (2021ZT09Y552)
Article History
Received: 4 September 2025
Accepted: 31 January 2026
First Online: 10 February 2026
Competing interests
: Gong Chen is a cofounder of NeuExcell Therapeutics Inc. The other authors have no conflicts of interest to declare.